Search research articles
Contact Us
Filters
Showing results (581-590 of 910) with videos related to
Page
of 91
Sort By:
The Journal of Chemical Physics
|
September 10, 2017
Dissipative particle dynamics: Systematic parametrization using water-octanol partition coefficients
Richard L Anderson, David J Bray, Andrea S Ferrante, et al.
American Journal of Clinical Dermatology
|
February 26, 2017
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study
Carle Paul, Craig Leonardi, Alan Menter, et al.
Reproduction, Fertility, and Development
|
January 1, 1995
Concentrations of corticotrophin-releasing hormone in the umbilical-cord blood of pregnancies complicated by pre-eclampsia
R S Goland, P J Tropper, W B Warren, et al.
The Journal of Parasitology
|
July 30, 2021
OPECHONA CHLOROSCOMBRI AND OPECHONA CORKUMI N. SP. (DIGENEA: LEPOCREADIIDAE) FROM THE NORTHERN GULF OF MEXICO WITH PHYLOGENETIC ANALYSIS BASED ON 28S RDNA
Stephen S Curran, Steven P Ksepka, Sergio R Martorelli, et al.
Journal of Developmental Physiology
|
August 1, 1992
Corticotropin releasing hormone concentrations in umbilical cord blood of preterm fetuses
P J Tropper, W B Warren, S M Jozak, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal
|
December 3, 2013
Physical properties of K(x)Ni(2-y)Se2 single crystals
Hechang Lei, Milinda Abeykoon, Kefeng Wang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 26, 2020
Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trial
R B Warren, J M Carrascosa, E Fumero, et al.
Advances in Therapy
|
March 22, 2022
Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis
Craig L Leonardi, Kyoungah See, Russel Burge, et al.
Advances in Therapy
|
September 2, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b Trial
Alice B Gottlieb, Richard B Warren, Matthias Augustin, et al.
Clinical and Experimental Dermatology
|
May 29, 2018
What's new in psoriasis treatment? An analysis of systematic reviews published in 2015
A C Foulkes, F Ferguson, D J C Grindlay, et al.
Page
of 91
Search research articles
Search
Showing results (581-590 of 910) with videos related to
Sort By:
Page
of 91
The Journal of Chemical Physics
|
September 10, 2017
Dissipative particle dynamics: Systematic parametrization using water-octanol partition coefficients
Richard L Anderson, David J Bray, Andrea S Ferrante, et al.
American Journal of Clinical Dermatology
|
February 26, 2017
Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study
Carle Paul, Craig Leonardi, Alan Menter, et al.
Reproduction, Fertility, and Development
|
January 1, 1995
Concentrations of corticotrophin-releasing hormone in the umbilical-cord blood of pregnancies complicated by pre-eclampsia
R S Goland, P J Tropper, W B Warren, et al.
The Journal of Parasitology
|
July 30, 2021
OPECHONA CHLOROSCOMBRI AND OPECHONA CORKUMI N. SP. (DIGENEA: LEPOCREADIIDAE) FROM THE NORTHERN GULF OF MEXICO WITH PHYLOGENETIC ANALYSIS BASED ON 28S RDNA
Stephen S Curran, Steven P Ksepka, Sergio R Martorelli, et al.
Journal of Developmental Physiology
|
August 1, 1992
Corticotropin releasing hormone concentrations in umbilical cord blood of preterm fetuses
P J Tropper, W B Warren, S M Jozak, et al.
Journal of Physics. Condensed Matter : an Institute of Physics Journal
|
December 3, 2013
Physical properties of K(x)Ni(2-y)Se2 single crystals
Hechang Lei, Milinda Abeykoon, Kefeng Wang, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 26, 2020
Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trial
R B Warren, J M Carrascosa, E Fumero, et al.
Advances in Therapy
|
March 22, 2022
Number Needed to Treat Network Meta-Analysis to Compare Biologic Drugs for Moderate-to-Severe Psoriasis
Craig L Leonardi, Kyoungah See, Russel Burge, et al.
Advances in Therapy
|
September 2, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b Trial
Alice B Gottlieb, Richard B Warren, Matthias Augustin, et al.
Clinical and Experimental Dermatology
|
May 29, 2018
What's new in psoriasis treatment? An analysis of systematic reviews published in 2015
A C Foulkes, F Ferguson, D J C Grindlay, et al.
Page
of 91